| Literature DB >> 15711051 |
Christian Mottet1, Pascal Juillerat, Jean-Jacques Gonvers, Florian Froehlich, Bernard Burnand, John-Paul Vader, Pierre Michetti, Christian Felley.
Abstract
Crohn's disease commonly affects women of childbearing age. Available data on Crohn's disease and pregnancy show that women with Crohn's disease can expect to conceive successfully, carry to term and deliver a healthy baby. Control of disease activity before conception and during pregnancy is critical, to optimize both maternal and fetal health. Generally speaking, pharmacological therapy for Crohn's disease during pregnancy is similar to pharmacological therapy for non-pregnant patients. Patients maintained in remission by way of pharmacological therapy should continue it throughout their pregnancy. Most drugs, including sulfasalazine, mesalazine, corticosteroids, and immunosuppressors such as azathioprine and 6-mercaptopurine, are safe, whereas methotrexate is contraindicated. Copyright (c) 2005 S. Karger AG, Basel.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15711051 DOI: 10.1159/000083874
Source DB: PubMed Journal: Digestion ISSN: 0012-2823 Impact factor: 3.216